MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-KR-03-0063286
Cymbio Pharma Private Limited - healthcare in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹30.28 Cr
▲ 46% YoY
Net profit · FY 2024
₹1.67 Cr
Net margin 5.5%
EBITDA · FY 2024
₹3.41 Cr
EBITDA margin 11.2%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹2.5 Cr
Issued & subscribed
Open charges
₹30.29 Cr
Satisfied ₹4.1 Cr
Company age
28 yrs
Est. 1998
Employees · EPFO
34
Provident fund records
About Cymbio Pharma Private Limited
Data last updated:
Cymbio Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 14 September 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U85110KA1998PTC024210. Its GSTIN is 29AABCC0047R1ZD (Karnataka).
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹2.5 Cr. It is led by directors including Sudarshan Karle and Mahendra Karle.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at No.23/4 Venkatala Yelahanka Hobli Yelahanka, Bangalore, Karnataka, India – 560064.
As per the financials filed for FY 2024, the company reported a revenue of ₹30.28 Cr, a growth of 46% compared to the previous year. For the same year it recorded a net profit of ₹1.67 Cr (net margin 5.5%) and EBITDA of ₹3.41 Cr (EBITDA margin 11.2%). Revenue has declined at a compounded annual rate (CAGR) of 24% over three years and 2% over five years.
The company has about 34 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Cymbio Pharma. As per MCA filings, the company has open charges of ₹30.29 Cr and satisfied charges of ₹4.1 Cr on record. Court records list 14 cases involving the company, including 4 filed by the company and 10 filed against it.
Cymbio Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0063286). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cymbio.co.in.
Company details
CIN U85110KA1998PTC024210
Registration Number 024210
Incorporation Date 14 September 1998
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KR-03-0063286
Recognitions & Rankings of Cymbio Pharma
Contact details
Cymbio Pharma Private Limited's registered office is in Bangalore, Karnataka. Its website is cymbio.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo.23/4 Venkatala Yelahanka Hobli Yelahanka, Bangalore, Karnataka, India – 560064
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Cymbio Pharma Private Limited, buy the company report.
Comprehensive company report
Cymbio Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Cymbio Pharma operates one associated brand: Cymbio Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Herbal extracts, phytochemicals, and cosmeceutical products manufacturing and exporting. | cymbio.co.in |
Business activity
The main business activity of Cymbio Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Cymbio Pharma Private Limited, buy the company report.
Financials of Cymbio Pharma Private Limited
FY 2023 filings availableCymbio Pharma Private Limited reported revenue of ₹30.28 Cr (up 46% YoY) for FY 2024.
Revenue · FY 2024
₹30.28 Cr ▲ 46%
Net profit · FY 2024
₹1.67 Cr margin 5.5%
EBITDA · FY 2024
₹3.41 Cr margin 11.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 46%
3 years · compounded
▲ 24%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▲ 139%
3 years · compounded
▲ 69%
5 years · compounded
▼ 10%
Revenue rose 46% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 139% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.41 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.67 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.2% | ||||
| Net Profit Margin | 5.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cymbio Pharma Private Limited, buy the company report.
Board of directors of Cymbio Pharma Private Limited
Cymbio Pharma has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudarshan Karle Also directs: Brain 'N' Beyond Biotech Private Limited, Karle Health Sciences Private Limited, Karle Tech Park Private Limited and 3 more | Director | 24 May 2003 | 23 Years 5 Months | Current |
| Mahendra Karle Also directs: Brain 'N' Beyond Biotech Private Limited, Karle Health Sciences Private Limited, Karle Tech Park Private Limited and 3 more | Director | 24 May 2003 | 23 Years 5 Months | Current |
| Fiona Karle | Director | 24 May 2004 | 22 Years 5 Months | Current |
| Kyung Seon Cho Also directs: Karle Infra Private Limited | Director | 24 May 2004 | 22 Years 5 Months | Current |
Peer comparison
Cymbio Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Panjon Limited | ₹30.77 Cr (FY 2025) | 137.0% | Indore, Madhya Pradesh, India | |||
| Charms Chem Private Limited | ₹30.55 Cr (FY 2024) | 13.0% | Maharashtra, India | |||
| Cymbio Pharma Private Limitedthis company | ₹30.28 Cr (FY 2024) | ₹1.67 Cr | 5.5% | 46.0% | 34 | Bangalore, Karnataka, India |
| Jupiter Pharmaceuticals Ltd | ₹30.22 Cr (FY 2025) | 12.0% | Kolkata, West Bengal, India | |||
| Sna Oushadhasala Private Limited | ₹30.17 Cr (FY 2025) | 19.0% | Thrissur, Kerala, India | |||
| Sreedhareeyam Farmherbs India Private Limited | ₹29.95 Cr (FY 2025) | 13.0% | Koothattukulam, Kerala, India | |||
| Peethambra Ayurved Bhawan Private Limited | ₹29.48 Cr (FY 2024) | 151.0% | New Delhi, Delhi, India |
To see the full peer comparison of Cymbio Pharma Private Limited, buy the company report.
Auditor
Cymbio Pharma Private Limited is audited by KV RADHAKRISHNA & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KV RADHAKRISHNA & CO | FY 2022 | 003302S |
Shareholding
The shareholding of Cymbio Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cymbio Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹30.29 Cr
Satisfied charges
₹4.1 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Feb 2025 | 101051171 | State Bank of India | ₹20 Cr | Open | |
| 31 Mar 2021 | 100436699 | Others | ₹35 Lakh | Open | |
| 26 Jun 2014 | 10509146 | Others | ₹9.94 Cr | Open | |
| 22 Apr 1999 | 90192054 | State Bank of India | ₹2.05 Cr | Satisfied | |
| 22 Apr 1999 | 90200372 | State Bank of India | ₹2.05 Cr | Satisfied |
To see the full charge records of Cymbio Pharma Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Cymbio Pharma Private Limited has 14 court cases on record: 4 filed by Cymbio Pharma, 10 filed against it. All cases are disposed.
Total cases
14
Filed by the company
4
Filed against the company
10
Disposed
14
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 8 | 6 | 0 |
| District courts | 6 | 4 | 0 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Criminal case | Filed against the company by Peenya Industrial Gases Pvt Ltd | Disposed |
| Bombay High Court | Court case (CHS) | Filed against the company by Excel Industries Limited | Disposed |
| High Court of Karnataka | Court case (OSA) | Filed by the company against M/S Excel Industries Limited | Disposed |
| District court, BENGALURU, Karnataka | Civil suit | Filed against the company by Chemmanur Extracts Pvt Ltd. | Disposed |
| Bombay High Court | Court case (SJ) | Filed against the company by Excel Industries Ltd. | Disposed |
To see the full case history of Cymbio Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cymbio Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Cymbio Pharma Private Limited has a workforce of 34 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
34
Active EPFO establishments
1
Employee growth
-22.73%
GST
Cymbio Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AABCC0047R1ZD | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cymbio Pharma Private Limited, buy the company report.
Recent activity
Cymbio Pharma Private Limited has 5 board changes on record since 2003: 4 appointments and 1 cessation. The latest: Amrita Ajith ceased to be Director on 06 May 2016.
Charges
A charge with State Bank Of India amounted to Rs. 20.00 Cr with Charge ID 101051171 was registered on 04 Feb 2025.
Charges
A charge with Others of Rs. 9.94 Cr registered on 26 Jun 2014 with Charge ID 10509146 was modified on 31 Jul 2024.
AGM
Cymbio Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Cymbio Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.
Charges
A charge with Others amounted to Rs. 0.35 Cr with Charge ID 100436699 was registered on 31 Mar 2021.
Charges
A charge registered on 22 Apr 1999 via Charge ID 90200372 with State Bank Of India was fully satisfied on 04 Jul 2019.
Ceased
Amrita Ajith ceased to be Director.
Charges
A charge registered on 22 Apr 1999 via Charge ID 90192054 with State Bank Of India was fully satisfied on 23 Jul 2014.
Charges
A charge with Others amounted to Rs. 9.94 Cr with Charge ID 10509146 was registered on 26 Jun 2014.
Appointed
Fiona Karle was appointed as Director.
Appointed
Kyung Seon Cho was appointed as Director.
Appointed
Mahendra Karle was appointed as Director.
6 earlier events are in the company report.
Frequently asked questions
Cymbio Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 14 September 1998 (28+ years old) and is registered under CIN U85110KA1998PTC024210.
Cymbio Pharma has 4 current directors:
- Sudarshan Karle - Director
- Mahendra Karle - Director
- Fiona Karle - Director
- Kyung Seon Cho - Director
The latest financial statements of Cymbio Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Cymbio Pharma is 29AABCC0047R1ZD, registered in Karnataka.
The CIN (Corporate Identification Number) of Cymbio Pharma is U85110KA1998PTC024210. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cymbio Pharma has 14 court cases on record: 4 filed by the company and 10 filed against it. Most are in the high courts.
Cymbio Pharma was incorporated on 14 September 1998, making it 28+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Cymbio Pharma by revenue are Panjon Limited, Charms Chem Private Limited, Jupiter Pharmaceuticals Ltd, Sna Oushadhasala Private Limited, Sreedhareeyam Farmherbs India Private Limited and 1 more, all in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Amrita Ajith ceased to be Director on 06 May 2016. Fiona Karle was appointed as Director on 24 May 2004. Kyung Seon Cho was appointed as Director on 24 May 2004. Cymbio Pharma has 5 board changes on record in total.
Yes, Cymbio Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-KR-03-0063286).
Cymbio Pharma can be reached through the website cymbio.co.in. Its registered office is in Bangalore, Karnataka, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages